Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iSpecimen (ISPC) Asset Writedowns and Impairment (2021 - 2025)

Historic Asset Writedowns and Impairment for iSpecimen (ISPC) over the last 5 years, with Q3 2025 value amounting to -$3521.0.

  • iSpecimen's Asset Writedowns and Impairment fell 38078.15% to -$3521.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $514017.0, marking a year-over-year increase of 9197.65%. This contributed to the annual value of $705724.0 for FY2024, which is 13135.53% up from last year.
  • iSpecimen's Asset Writedowns and Impairment amounted to -$3521.0 in Q3 2025, which was down 38078.15% from -$93463.0 recorded in Q2 2025.
  • In the past 5 years, iSpecimen's Asset Writedowns and Impairment registered a high of $499960.0 during Q4 2024, and its lowest value of -$234277.0 during Q4 2022.
  • Over the past 5 years, iSpecimen's median Asset Writedowns and Impairment value was $61986.0 (recorded in 2023), while the average stood at $68025.0.
  • As far as peak fluctuations go, iSpecimen's Asset Writedowns and Impairment soared by 133590.77% in 2022, and later tumbled by 151911.63% in 2025.
  • iSpecimen's Asset Writedowns and Impairment (Quarter) stood at $127218.0 in 2021, then plummeted by 284.15% to -$234277.0 in 2022, then skyrocketed by 126.46% to $61986.0 in 2023, then surged by 706.57% to $499960.0 in 2024, then plummeted by 100.7% to -$3521.0 in 2025.
  • Its Asset Writedowns and Impairment was -$3521.0 in Q3 2025, compared to -$93463.0 in Q2 2025 and $111041.0 in Q1 2025.